Correction: ERManI Is a Target of miR-125b and Promotes Transformation Phenotypes in Hepatocellular Carcinoma (HCC).
Main Authors: | Shujuan Pan, Xiaoyun Cheng, Hongan Chen, Patricia D. Castro, Michael M. Ittmann, Anne W. Hutson, Susan K. Zapata, Richard N. Sifers |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3879398 |
Similar Items
-
ERManI is a target of miR-125b and promotes transformation phenotypes in hepatocellular carcinoma (HCC).
by: Shujuan Pan, et al.
Published: (2013-01-01) -
Correction: ERManI Is a Target of miR-125b and Promotes Transformation Phenotypes in Hepatocellular Carcinoma (HCC)
Published: (2014-01-01) -
Implication of miR-122, miR-483, and miR-335 Expression Levels as Potential Signatures in HCV-Related Hepatocellular Carcinoma (HCC) in Egyptian Patients
by: Ashraf Y. Elfert, et al.
Published: (2022-05-01) -
Identification of Circulating Exosomal miR-101 and miR-125b Panel Act as a Potential Biomarker for Hepatocellular Carcinoma
by: Li Sun, et al.
Published: (2021-01-01) -
Fungal Assemblages in Different Habitats in an Erman’s Birch Forest
by: Teng Yang, et al.
Published: (2016-08-01)